Therefore, the pre-existinganti-cancer activity of high-risk score patients may be limited by high levels of tumor-infiltrating macrophages (M2) and overexpression of many inhibitory immune checkpoints such as TGFBR1 and KDR. Here, TGFBR1 is linked to neoplasm.